IASLC Lung Cancer News (ILCN), February 2023
ILCN | English
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Table of Contents
  • CodeBreaK 200 Confirms Sotorasib’s Superiority Compared to Docetaxel, Investigator Says
  • Tobacco Smoking-Related Mutational Signatures: Is it Time to Move on From Patient-Reported History?
  • TTLC 2023 Showcases Early Ongoing Trial Data, Newest Therapies
  • Patient Perspective: Me, Myself, and Scanxiety
  • In Brief for Feb. 22, 2023
  • Multifaceted Approach Needed for Early Lung Cancer Detection
  • Increasing Evidence Demonstrates the Usefulness of ctDNA
  • Education Award Recipients Recognized at Latin America Conference
  • Committee Update: Advocates Offer Unique Support to Members, Help Investigators Understand Patients
  • In Brief for Feb. 8, 2023
IASLC Lung Cancer News (ILCN) is the offical news source of the only global association dedicated to the multidisciplinary study of lung cancer, published bimonthly by the International Association for the Study of Lung Cancer (IASLC). 

Click here to link to Submission Guidelines.
Powered By